BioCentury
ARTICLE | Company News

Brahms, Thermo Fisher deal

September 14, 2009 7:00 AM UTC

Thermo Fisher will acquire diagnostic company Brahms for €330 million ($473 million) in cash. Brahms markets its Procalcitonin (PCT) sepsis diagnostic in Europe and has a development pipeline focused ...